Diagnos Laboratorium Utama PT Tbk Asset Resilience Ratio

Latest as of June 2025: 0.32%

Diagnos Laboratorium Utama PT Tbk asset resilience ratio. Diagnos Laboratorium Utama PT Tbk (DGNS) has an Asset Resilience Ratio of 0.32% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Diagnos Laboratorium Utama PT Tbk defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rp959.59 Million
≈ $56.23K USD Cash + Short-term Investments

Total Assets

Rp304.08 Billion
≈ $17.82 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Diagnos Laboratorium Utama PT Tbk (2021–2024)

Asset resilience ratio of Diagnos Laboratorium Utama PT Tbk from 2021 to 2024. This chart shows how Diagnos Laboratorium Utama PT Tbk's Asset Resilience Ratio has changed over time. Read Diagnos Laboratorium Utama PT Tbk (DGNS) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Diagnos Laboratorium Utama PT Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Diagnos Laboratorium Utama PT Tbk total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rp0.00 0%
Short-term Investments Rp959.59 Million 0.32%
Total Liquid Assets Rp959.59 Million 0.32%

Asset Resilience Insights

  • Limited Liquidity: Diagnos Laboratorium Utama PT Tbk maintains only 0.32% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Diagnos Laboratorium Utama PT Tbk Industry Peers by Asset Resilience Ratio

Compare Diagnos Laboratorium Utama PT Tbk's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Revvity Inc.
NYSE:RVTY
Diagnostics & Research 0.00%
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
Diagnostics & Research 0.14%
Vijaya Diagnostic Centre Limited
NSE:VIJAYA
Diagnostics & Research 15.15%
Sonic Healthcare Ltd
AU:SHL
Diagnostics & Research 0.13%
Integral Diagnostics Ltd
AU:IDX
Diagnostics & Research 0.03%
Australian Clinical Labs Ltd
AU:ACL
Diagnostics & Research 4.11%
Healius Ltd
AU:HLS
Diagnostics & Research 0.06%
Monash Ivf Group Ltd
AU:MVF
Diagnostics & Research 1.60%

Diagnos Laboratorium Utama PT Tbk Asset Resilience Ratio by Year (2021–2024)

Diagnos Laboratorium Utama PT Tbk asset resilience ratio by year from 2021 to 2024. The table below shows the annual Asset Resilience Ratio data for Diagnos Laboratorium Utama PT Tbk.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.32% Rp959.59 Million
≈ $56.23K
Rp300.02 Billion
≈ $17.58 Million
-0.30pp
2023-12-31 0.62% Rp1.70 Billion
≈ $99.37K
Rp271.48 Billion
≈ $15.91 Million
-0.44pp
2022-12-31 1.06% Rp2.54 Billion
≈ $148.99K
Rp239.94 Billion
≈ $14.06 Million
-1.63pp
2021-12-31 2.69% Rp6.51 Billion
≈ $381.30K
Rp241.98 Billion
≈ $14.18 Million
--
pp = percentage points

About Diagnos Laboratorium Utama PT Tbk

JK:DGNS Indonesia Diagnostics & Research
Market Cap
$20.66 Million
Rp352.50 Billion IDR
Market Cap Rank
#24841 Global
#517 in Indonesia
Share Price
Rp282.00
Change (1 day)
-6.00%
52-Week Range
Rp142.00 - Rp328.00
All Time High
Rp1408.74
About

PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; and genomics laboratory tests that provides genetic testing for reproductive health, pregnant women, couples who want t… Read more